Project Details
Description
Disruption of breast cancer chemoresistance by the translational antagonist 4E-BP1: a bitransgenic mouse model
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/08 → 4/30/10 |
Funding
- MN MED FDN
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.